Treatment of ovarian cancer with intraperitoneal chemotherapy Journal Article
| Author: | Hydzik, C. |
| Article Title: | Treatment of ovarian cancer with intraperitoneal chemotherapy |
| Abstract: | In early 2006, the National Cancer Institute (NCI) issued a Clinical Announcement suggesting that intraperitoneal (IP) chemotherapy should become the standard of care for patients with newly diagnosed stage III optimally debulked epithelial ovarian cancer. IP chemotherapy, the administration of chemotherapy or biologic therapy via catheter into the peritoneal space, is new to many healthcare providers (physicians, nurses, and pharmacists). The goals of this article are to address the rationale for IP chemotherapy, present the data supporting its use, and describe the nursing management of patients undergoing this treatment. Education of patients and staff regarding IP therapy is essential for successful patient outcomes. |
| Keywords: | disease-free survival; mortality; antineoplastic agents; united states; disease free survival; methodology; antineoplastic agent; ovarian neoplasms; incidence; survivor; survivors; standard; ovary tumor; safety; national cancer institute (u.s.); infusion; national health organization; infusions, parenteral |
| Journal Title: | Oncology (Norwalk) |
| Volume: | 23 |
| Issue: | 11 Suppl. Nurse Ed. |
| ISSN: | 0890-9091 |
| Publisher: | C M P Medica LLC * The Oncology Group |
| Date Published: | 2009-10-01 |
| Start Page: | 15 |
| End Page: | 20 |
| Language: | English |
| PUBMED: | 19856603 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 1" - "Export Date: 30 November 2010" - "Source: Scopus" |
